Tandlægeholdingselskabet Mogens Buskbjerg ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 9.5% 6.8% 9.3% 15.4%  
Credit score (0-100)  0 27 35 25 12  
Credit rating  N/A B BB B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Gross profit  0.0 -4.0 -4.0 -8.0 -3.9  
EBITDA  0.0 -4.0 -4.0 -8.0 -3.9  
EBIT  0.0 -4.0 -4.0 -8.0 -3.9  
Pre-tax profit (PTP)  0.0 19.0 -4.0 -35.0 -16.8  
Net earnings  0.0 20.0 -3.0 -34.0 -19.6  
Pre-tax profit without non-rec. items  0.0 19.0 -4.0 -35.0 -16.8  

 
See the entire income statement

Balance sheet (kDKK) 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 60.0 57.0 23.0 3.7  
Interest-bearing liabilities  0.0 0.0 0.0 14.0 18.1  
Balance sheet total (assets)  0.0 64.0 65.0 41.0 25.6  

Net Debt  0.0 -30.0 -30.0 -14.0 -7.5  
 
See the entire balance sheet

Volume 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -4.0 -4.0 -8.0 -3.9  
Gross profit growth  0.0% 0.0% 0.0% -100.0% 51.6%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 64 65 41 26  
Balance sheet change%  0.0% 0.0% 1.6% -36.9% -37.5%  
Added value  0.0 -4.0 -4.0 -8.0 -3.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 29.7% -6.2% -58.5% -11.6%  
ROI %  0.0% 31.7% -6.8% -66.0% -13.2%  
ROE %  0.0% 33.3% -5.1% -85.0% -146.4%  

Solidity 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Equity ratio %  0.0% 93.8% 87.7% 56.1% 14.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 750.0% 750.0% 175.0% 193.1%  
Gearing %  0.0% 0.0% 0.0% 60.9% 485.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 57.1% 80.5%  

Liquidity 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Quick Ratio  0.0 7.8 4.0 1.7 1.2  
Current Ratio  0.0 7.8 4.0 1.7 1.2  
Cash and cash equivalent  0.0 30.0 30.0 28.0 25.6  

Capital use efficiency 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 27.0 24.0 13.0 3.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0